Propanc Biopharma, Inc.
PPCB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517681
No open-market purchases or sales by Propanc Biopharma, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $71.5K in total; no superinvestor holds it.
Holders of 5% or more of PPCB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Propanc Biopharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Propanc Biopharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Propanc Biopharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:05 PM ET | Ionic Ventures, LLCand 3 others | 13G/A | 0.00%0 shares | −9.90 ppfrom 9.90%Below 5% | Sep 30, 2025 | SEC |
| Aug 19, 20254:20 PM ET | Ionic Ventures, LLCand 3 others | 13G | 9.90%1.26M shares | New | Aug 14, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Propanc Biopharma, Inc. shares.
No Form 144 notices for Propanc Biopharma, Inc. are on file.